Research Support
Investigators:Esmaeili, Sara 11-01-2025 -10-31-2026 TG Therapeutics, Inc. Real-World Insights into Treatment with Ublituximab for Relapsing-Remitting Multiple Sclerosis (RRMS) at UC Health Role:PI 38076.78 Hold Level:Industry
Investigators:Esmaeili, Sara 11-01-2025 -10-31-2026 TG Therapeutics, Inc. Real-World Insights into Treatment with Ublituximab for Relapsing-Remitting Multiple Sclerosis (RRMS) at UC Health Role:PI 38076.78 Hold Level:Industry